There are a number of studies that have looked at the use of intravenous immunoglobulin therapy in Alzheimer Disease and there is no evidence of benefit. There are some rarer infections of the central nervous system, associated with loss of higher or cognitive function and good immunoglobulin treatment prevents these infections from taking hold.
Veins can usually recover in the 3-week gap. If your veins do become brittle then your immunology team might recommend changing to another way of giving immunoglobulin such as subcutaneous infusion.
The risk of transmissible infection is as low as possible with an appropriate screening of donors and donor pools of plasma before they are manufactured into Ig, but the risk isn't zero. Plasma is treated in a few different ways to get rid of the infection. Depending on the manufacturer, the plasma will get a
Some patients have conditions that improve over time e.g. secondary antibody deficiency, in such cases taking someone off immunoglobulin to see if their own immunity is improved can be a very positive step.
Immunoglobulin costs £40-65 per gram so a typical replacement dose is about £2300 on top of which there will also be administration charges and a day care fee. You would need to see a private doctor to discuss this with them.
Once doctors have exhausted the possibility of finding a related donor within the family then they will begin the search of a match on national registries such as the Anthony Nolan Registry and cord stem cell banks. Searches can also be made worldwide through international registries. Umbilical cord blood may be used, and haploidentical transplants
BMT works best when there is a 100% or 90% match of important markers on cells between the donor and the person having the BMT. A brother or sister has a 25% chance of being a perfect match and are often used as donors. A parent is usually only a 50% match so traditionally not always
Usually adults who are being considered for BMT have had chronic problems such as lung and gut disease over a long period of time. The accumulation of tissue damage from these chronic problems and infections often make BMT more difficult. Also because of the risks of BMT, the choices of whether a BMT is the
No over the past few years, more adults have started to be treated by BMT but the numbers are still low. One recent major advance has been the development of what is known as ‘reduced-intensity conditioning’; this is a milder form of chemotherapy used to prepare the patient for the donor’s bone marrow. This has
This depends on the type of CVID, its genetic basis and the health problems, past and present that the person may have. CVID is probably a collection of multiple genetic disorders with sufficient common features for them to be given the same umbrella diagnostic label. From our current understanding, some immune deficiency is caused by
IMPORTANT NOTE: The information contained on this website is intended only as a guideline, not as a substitute for medical advice. Always consult your doctor
if you or your child has any immunodeficiency symptoms or concerns. © 2025 Immunodeficiency UK. All rights reserved | Registered charity number 1193166.
